Financial statements Cergopharma

Balance sheet of Cergopharma

Company age:
Age:
11 y. 5 m. 7 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of CERGOPHARMA

Year
2018
2019
2020
2021
2022
Total assets 193 733,60 266 118,29 386 767,14 1 042 055,96 1 564 054,04
A. Fixed assets 7 466,76 1 866,84 77 904,11 477 311,02 554 373,77
B. Current assets 186 266,84 264 251,45 308 863,03 564 744,94 1 009 680,27
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 193 733,60 266 118,29 386 767,34 1 042 055,96 1 564 054,04
A. Equity 170 428,71 252 874,04 269 167,29 494 659,64 574 547,92
B. Liabilities and provisions for liabilities 23 304,89 13 244,25 117 599,85 547 396,32 989 506,12
I. Long-term liabilities - - - - -
II. Short-term liabilities - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.